{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:21:05Z","timestamp":1793308865058,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81171604"],"award-info":[{"award-number":["81171604"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271857"],"award-info":[{"award-number":["81271857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["20110491573"],"award-info":[{"award-number":["20110491573"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.vaccine.2013.07.065","type":"journal-article","created":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T17:45:18Z","timestamp":1375811118000},"page":"4536-4540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB\/c mice against type II parasite infection"],"prefix":"10.1016","volume":"31","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12-13","key":"10.1016\/j.vaccine.2013.07.065_bib0005","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"International Journal for Parasitology"},{"issue":"66","key":"10.1016\/j.vaccine.2013.07.065_bib0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1550-7408.2008.00345.x","article-title":"The history of Toxoplasma gondii \u2013 the first 100 years","volume":"55","author":"Dubey","year":"2008","journal-title":"Journal of Eukaryotic Microbiology"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.065_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1863-2378.2009.01276.x","article-title":"A brief history and overview of Toxoplasma gondii","volume":"57","author":"Innes","year":"2010","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.vaccine.2013.07.065_bib0020","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.065_bib0025","first-page":"1158","article-title":"Toxoplasmosis in HIV\/AIDS: a living legacy","volume":"40","author":"Nissapatorn","year":"2009","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.065_bib0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.meegid.2012.01.013","article-title":"Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France","volume":"12","author":"Vittecoq","year":"2012","journal-title":"Infection, Genetics and Evolution"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.065_bib0035","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1176\/appi.neuropsych.12100234","article-title":"Latent Toxoplasmosis gondii: emerging evidence for influences on neuropsychiatric disorders","volume":"24","author":"Hurley","year":"2012","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.065_bib0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09273948.2011.564068","article-title":"Clinical manifestations of ocular toxoplasmosis","volume":"19","author":"Delair","year":"2011","journal-title":"Ocular Immunology and Inflammation"},{"issue":"1589","key":"10.1016\/j.vaccine.2013.07.065_bib0045","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1098\/rspb.2005.3413","article-title":"Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour","volume":"273","author":"Webster","year":"2006","journal-title":"Proceedings of the Royal Society B: Biological Sciences"},{"issue":"47","key":"10.1016\/j.vaccine.2013.07.065_bib0050","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1016\/j.vaccine.2009.08.043","article-title":"Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice","volume":"27","author":"Peng","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.065_bib0055","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.vaccine.2010.11.002","article-title":"Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis","volume":"29","author":"Dziadek","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.065_bib0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1756-3305-6-63","article-title":"Compound DNA vaccine encoding SAG1\/SAG3 with A2\/B subunit of cholera toxin as a genetic adjuvant protects BALB\/c mice against Toxoplasma gondii","volume":"13","author":"Cong","year":"2013","journal-title":"Parasites & Vectors"},{"key":"10.1016\/j.vaccine.2013.07.065_bib0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-444-53490-3.00008-X","article-title":"Toxoplasmosis","volume":"114","author":"Halonen","year":"2013","journal-title":"Handbook of Clinical Neurology"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.065_bib0070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.micinf.2003.11.009","article-title":"The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection","volume":"6","author":"Cristina","year":"2004","journal-title":"Microbes and Infection"},{"issue":"14","key":"10.1016\/j.vaccine.2013.07.065_bib0075","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1074\/jbc.M808714200","article-title":"Structural characterization of the bradyzoite surface antigen (BSR4) from Toxoplasma gondii, a unique addition to the surface antigen glycoprotein 1-related superfamily","volume":"284","author":"Crawford","year":"2009","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.065_bib0080","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1128\/IAI.01494-07","article-title":"A cluster of four surface antigen genes specifically expressed in bradyzoites, SAG2CDXY, plays an important role in Toxoplasma gondii persistence","volume":"76","author":"Saeij","year":"2008","journal-title":"Infection and Immunity"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.065_bib0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpara.2003.12.004","article-title":"The SRS superfamily of Toxoplasma surface proteins","volume":"34","author":"Jung","year":"2004","journal-title":"International Journal for Parasitology"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.065_bib0090","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/s00436-013-3416-1","article-title":"Upregulated expression of Tim-3 involved in the process of toxoplasmic encephalitis in mouse model","volume":"112","author":"Wu","year":"2013","journal-title":"Parasitology Research"},{"issue":"31","key":"10.1016\/j.vaccine.2013.07.065_bib0095","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.vaccine.2008.04.046","article-title":"Multi-epitope DNA vaccine linked to the A2\/B subunit of cholera toxin protect mice against Toxoplasma gondii","volume":"26","author":"Cong","year":"2008","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2013.07.065_bib0100","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.vaccine.2011.01.089","article-title":"Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II","volume":"29","author":"Tan","year":"2011","journal-title":"Vaccine"},{"issue":"1-2","key":"10.1016\/j.vaccine.2013.07.065_bib0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.vetpar.2006.03.018","article-title":"Comparative infectivity of oocysts and bradyzoites of Toxoplasma gondii for intermediate (mice) and definitive (cats) hosts","volume":"140","author":"Dubey","year":"2006","journal-title":"Veterinary Parasitology"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.065_bib0110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00436-010-1899-6","article-title":"Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion","volume":"107","author":"Skariah","year":"2010","journal-title":"Parasitology Research"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.065_bib0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0253-7184.81255","article-title":"Successful treatment of cerebral toxoplasmosis with cotrimoxazole","volume":"32","author":"Patil","year":"2011","journal-title":"Indian Journal of Sexually Transmitted Diseases"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.065_bib0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1574-6976.2011.00305.x","article-title":"Mechanisms of Toxoplasma gondii persistence and latency","volume":"36","author":"Sullivan","year":"2012","journal-title":"FEMS Microbiology Review"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.065_bib0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000180267","article-title":"Neuropsychiatric disease and Toxoplasma gondii infection","volume":"16","author":"Henriquez","year":"2009","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.065_bib0130","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1128\/IAI.68.3.1026-1033.2000","article-title":"B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii","volume":"68","author":"Sayles","year":"2000","journal-title":"Infection and Immunity"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.065_bib0135","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","article-title":"Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase","volume":"164","author":"Kang","year":"2000","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.065_bib0140","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis","volume":"34","author":"Dupont","year":"2012","journal-title":"Seminars in Immunopathology"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.065_bib0145","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4049\/jimmunol.182.2.1069","article-title":"Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th-1 host immune responses in the absence of parasite replication","volume":"182","author":"Gigley","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.vaccine.2013.07.065_bib0150","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1017\/S1462399411002018","article-title":"Interferon-gamma and perforin-mediated immune responses for resistance in the brain against Toxoplasma gondii","volume":"13","author":"Suzuki","year":"2011","journal-title":"Expert Reviews in Molecular Medicine"},{"issue":"9","key":"10.1016\/j.vaccine.2013.07.065_bib0155","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.pt.2011.03.009","article-title":"Innate responses to Toxoplasma gondii in mice and humans","volume":"27","author":"Pifer","year":"2011","journal-title":"Trends in Parasitology"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.065_bib0160","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.vaccine.2010.11.015","article-title":"Towards an immunosense vaccine to prevent toxoplasmosis: Protective Toxoplasma gondii epitopes restricted by HLA-A*0201","volume":"29","author":"Cong","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.065_bib0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1749-6632.2009.05135.x","article-title":"Cross-presentation of peptides from intracellular pathogens by MHC class I molecules","volume":"1183","author":"Blanchard","year":"2010","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.vaccine.2013.07.065_bib0165","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/165342","article-title":"Analysis of structures and epitopes of surface antigen glycoproteins expressed in bradyzoites of Toxoplasma gondii","author":"Cong","year":"2013","journal-title":"BioMed Research International"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.065_bib0170","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","article-title":"Toxoplasma gondii comprises 3 clonal lineages: correlation of parasitic genotype with human disease","volume":"172","author":"Howe","year":"1995","journal-title":"Infectious Diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.065_bib0175","doi-asserted-by":"crossref","first-page":"e53483","DOI":"10.1371\/journal.pone.0053483","article-title":"Genotypes and mouse virulence of Toxoplasma gondii isolates from animals and humans in China","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13010517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13010517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T15:37:37Z","timestamp":1731339457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13010517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":36,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0264410X13010517"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB\/c mice against type II parasite infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}